schliessen

Filtern

 

Bibliotheken

Progress in Nephron Sparing Therapy for Renal Cell Carcinoma and von Hippel-Lindau Disease.(Report)

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.juro.2011.02.007 Byline: Dominique Joly (a)(b)(g)(h)(i), Arnaud Mejean (a)(c)(h)(i), Jean-Michel Correas (a)(d)(h)(i), Marc-Olivier Timsit (a)(c)(h)(i), Virginie Verkarre (f)(h)(i), Sophie Deveaux (h)(i), Paul... Full description

Journal Title: The Journal of Urology June, 2011, Vol.185(6), p.2056(5)
Main Author: Joly, D.
Other Authors: Méjean, A. , Corréas, J.-M. , Timsit, M.-O. , Verkarre, V. , Deveaux, S. , Landais, P. , Grünfeld, J.-P. , Richard, S.,
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: ISSN: 0022-5347
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: gale_ofa256416180
title: Progress in Nephron Sparing Therapy for Renal Cell Carcinoma and von Hippel-Lindau Disease.(Report)
format: Article
creator:
  • Joly, D.
  • Méjean, A.
  • Corréas, J.-M.
  • Timsit, M.-O.
  • Verkarre, V.
  • Deveaux, S.
  • Landais, P.
  • Grünfeld, J.-P.
  • Richard, S.
subjects:
  • Renal Cell Carcinoma -- Care And Treatment
  • Cancer Metastasis -- Care And Treatment
  • Antineoplastic Agents -- Evaluation
  • Cancer Treatment
  • Ablation (Surgery)
ispartof: The Journal of Urology, June, 2011, Vol.185(6), p.2056(5)
description: To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.juro.2011.02.007 Byline: Dominique Joly (a)(b)(g)(h)(i), Arnaud Mejean (a)(c)(h)(i), Jean-Michel Correas (a)(d)(h)(i), Marc-Olivier Timsit (a)(c)(h)(i), Virginie Verkarre (f)(h)(i), Sophie Deveaux (h)(i), Paul Landais (a)(b)(e), Jean-Pierre Grunfeld (a)(b), Stephane Richard (a)(b)(h)(i)(j)(k) Keywords: kidney; carcinoma; renal cell; von Hippel-Lindau disease; catheter ablation; France Abbreviations: GFR, glomerular filtration rate; NSS, nephron sparing surgery; RCC, renal cell carcinoma; RFA, radio frequency ablation; VHL, von Hippel Lindau Abstract: Patients with von Hippel-Lindau disease frequently have early, multiple and recurrent renal cell carcinoma. Renal cell carcinoma treatment, which must prevent metastatic disease and spare nephrons, has changed in the last 2 decades. We evaluated renal cell carcinoma treatments in the long term in a large series of patients with von Hippel-Lindau disease. Author Affiliation: (a) Faculte de Medicine, Universite Paris Descartes, Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (b) Service de Nephrologie, Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (c) Service d'Urologie, Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (d) Service de Radiologie, Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (e) Service de Biostatistique (EA 4067), Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (f) Service d'Anatomie Pathologique, Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (g) Institut National de la Sante et de la Recherche Medicale U845, HA[acute accent]pital Necker-Enfants Malades, Paris, France (h) Centre de Reference Cancers Rares Institut National du Cancer, Predispositions hereditaires au cancer du rein de l'adulte, Assistance Publique-HA[acute accent]pitaux de Paris, Le Kremlin-BicA*tre, France (i) Service d'Urologie, HA[acute accent]pital de BicA*tre, Le Kremlin-BicA*tre, France (j) Genetique Oncologique Ecole Pratique des Hautes Etudes, Institut National de la Sante et de la Recherche Medicale U753, Institut de cancerologie Gustave Roussy Villejuif, Le Kremlin-BicA*tre, France (k) Faculte de Medecine Paris-Sud, Le Kremlin-BicA*tre, France Article History: Received 12 October 2010 Article Note: (footnote) Supported by grants from the French National Cancer Institute, Rein and Reseau National Predispositions her
language: English
source:
identifier: ISSN: 0022-5347
fulltext: fulltext
issn:
  • 0022-5347
  • 00225347
url: Link


@attributes
ID1437648459
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid256416180
sourceidgale_ofa
recordidTN_gale_ofa256416180
sourceformatXML
sourcesystemOther
pqid874194905
galeid256416180
display
typearticle
titleProgress in Nephron Sparing Therapy for Renal Cell Carcinoma and von Hippel-Lindau Disease.(Report)
ispartofThe Journal of Urology, June, 2011, Vol.185(6), p.2056(5)
identifierISSN: 0022-5347
subjectRenal Cell Carcinoma -- Care And Treatment ; Cancer Metastasis -- Care And Treatment ; Antineoplastic Agents -- Evaluation ; Cancer Treatment ; Ablation (Surgery)
descriptionTo link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.juro.2011.02.007 Byline: Dominique Joly (a)(b)(g)(h)(i), Arnaud Mejean (a)(c)(h)(i), Jean-Michel Correas (a)(d)(h)(i), Marc-Olivier Timsit (a)(c)(h)(i), Virginie Verkarre (f)(h)(i), Sophie Deveaux (h)(i), Paul Landais (a)(b)(e), Jean-Pierre Grunfeld (a)(b), Stephane Richard (a)(b)(h)(i)(j)(k) Keywords: kidney; carcinoma; renal cell; von Hippel-Lindau disease; catheter ablation; France Abbreviations: GFR, glomerular filtration rate; NSS, nephron sparing surgery; RCC, renal cell carcinoma; RFA, radio frequency ablation; VHL, von Hippel Lindau Abstract: Patients with von Hippel-Lindau disease frequently have early, multiple and recurrent renal cell carcinoma. Renal cell carcinoma treatment, which must prevent metastatic disease and spare nephrons, has changed in the last 2 decades. We evaluated renal cell carcinoma treatments in the long term in a large series of patients with von Hippel-Lindau disease. Author Affiliation: (a) Faculte de Medicine, Universite Paris Descartes, Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (b) Service de Nephrologie, Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (c) Service d'Urologie, Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (d) Service de Radiologie, Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (e) Service de Biostatistique (EA 4067), Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (f) Service d'Anatomie Pathologique, Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (g) Institut National de la Sante et de la Recherche Medicale U845, HA[acute accent]pital Necker-Enfants Malades, Paris, France (h) Centre de Reference Cancers Rares Institut National du Cancer, Predispositions hereditaires au cancer du rein de l'adulte, Assistance Publique-HA[acute accent]pitaux de Paris, Le Kremlin-BicA*tre, France (i) Service d'Urologie, HA[acute accent]pital de BicA*tre, Le Kremlin-BicA*tre, France (j) Genetique Oncologique Ecole Pratique des Hautes Etudes, Institut National de la Sante et de la Recherche Medicale U753, Institut de cancerologie Gustave Roussy Villejuif, Le Kremlin-BicA*tre, France (k) Faculte de Medecine Paris-Sud, Le Kremlin-BicA*tre, France Article History: Received 12 October 2010 Article Note: (footnote) Supported by grants from the French National Cancer Institute, Rein and Reseau National Predispositions hereditaires au cancer du rein and French Ligue Nationale contre le Cancer, Comites du Cher, de l'Indre et de l'Allier., For another article on a related topic see page 2353 .
languageEnglish
source
creatorJoly, D. ; Méjean, A. ; Corréas, J.-M. ; Timsit, M.-O. ; Verkarre, V. ; Deveaux, S. ; Landais, P. ; Grünfeld, J.-P. ; Richard, S.;
version5
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
search
scope
0gale_onefilea
1gale_onefileg
2OneFile
titleProgress in Nephron Sparing Therapy for Renal Cell Carcinoma and von Hippel-Lindau Disease.(Report)
descriptionTo link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.juro.2011.02.007 Byline: Dominique Joly (a)(b)(g)(h)(i), Arnaud Mejean (a)(c)(h)(i), Jean-Michel Correas (a)(d)(h)(i), Marc-Olivier Timsit (a)(c)(h)(i), Virginie Verkarre (f)(h)(i), Sophie Deveaux (h)(i), Paul Landais (a)(b)(e), Jean-Pierre Grunfeld (a)(b), Stephane Richard (a)(b)(h)(i)(j)(k) Keywords: kidney; carcinoma; renal cell; von Hippel-Lindau disease; catheter ablation; France Abbreviations: GFR, glomerular filtration rate; NSS, nephron sparing surgery; RCC, renal cell carcinoma; RFA, radio frequency ablation; VHL, von Hippel Lindau Abstract: Patients with von Hippel-Lindau disease frequently have early, multiple and recurrent renal cell carcinoma. Renal cell carcinoma treatment, which must prevent metastatic disease and spare nephrons, has changed in the last 2 decades. We evaluated renal cell carcinoma treatments in the long term in a large series of patients with von Hippel-Lindau disease. Author Affiliation: (a) Faculte de Medicine, Universite Paris Descartes, Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (b) Service de Nephrologie, Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (c) Service d'Urologie, Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (d) Service de Radiologie, Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (e) Service de Biostatistique (EA 4067), Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (f) Service d'Anatomie Pathologique, Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (g) Institut National de la Sante et de la Recherche Medicale U845, HA[acute accent]pital Necker-Enfants Malades, Paris, France (h) Centre de Reference Cancers Rares Institut National du Cancer, Predispositions hereditaires au cancer du rein de l'adulte, Assistance Publique-HA[acute accent]pitaux de Paris, Le Kremlin-BicA*tre, France (i) Service d'Urologie, HA[acute accent]pital de BicA*tre, Le Kremlin-BicA*tre, France (j) Genetique Oncologique Ecole Pratique des Hautes Etudes, Institut National de la Sante et de la Recherche Medicale U753, Institut de cancerologie Gustave Roussy Villejuif, Le Kremlin-BicA*tre, France (k) Faculte de Medecine Paris-Sud, Le Kremlin-BicA*tre, France Article History: Received 12 October 2010 Article Note: (footnote) Supported by grants from the French National Cancer Institute, Rein and Reseau National Predispositions hereditaires au cancer du rein and French Ligue Nationale contre le Cancer, Comites du Cher, de l'Indre et de l'Allier., For another article on a related topic see page 2353 .
subject
0Renal cell carcinoma--Care and treatment
1Cancer metastasis--Care and treatment
2Antineoplastic agents--Evaluation
32834
4Pharmaceutical preparations
5Ambulatory Health Care Services
6Pharmaceutical Preparation Manufacturing
7621
8325412
9Antineoplastic agents
10Cancer
general
0English
1Elsevier B.V.
2Cengage Learning, Inc.
sourceidgale_ofa
recordidgale_ofa256416180
issn
00022-5347
100225347
rsrctypearticle
creationdate2011
recordtypearticle
addtitleThe Journal of Urology
searchscopeOneFile
lsr30VSR-Enriched:[pages, eissn, creator, pqid, doi, galeid]
sort
titleProgress in Nephron Sparing Therapy for Renal Cell Carcinoma and von Hippel-Lindau Disease.(Report)
creationdate20110601
facets
frbrgroupid9184099426787005866
frbrtype5
languageeng
creationdate2011
topic
0Renal Cell Carcinoma–Care And Treatment
1Cancer Metastasis–Care And Treatment
2Antineoplastic Agents–Evaluation
3Cancer Treatment
4Ablation (Surgery)
collectionOneFile (GALE)
prefilterarticles
rsrctypearticles
jtitleThe Journal of Urology
toplevelpeer_reviewed
frbr
t2
k12011
k200225347
k4185
k56
k62056
k7journal of urology
k8progress in nephron sparing therapy for renal cell carcinoma von hippel lindau disease
k9progressinnephronspasease
k12progressinnephronsparingt
delivery
delcategoryRemote Search Resource
fulltextfulltext
ranking
booster11
booster21
pcg_typeaggregator
addata
atitleProgress in Nephron Sparing Therapy for Renal Cell Carcinoma and von Hippel-Lindau Disease.(Report)
jtitleThe Journal of Urology
risdate20110601
volume185
issue6
spage2056
issn0022-5347
genrearticle
ristypeJOUR
abstractTo link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.juro.2011.02.007 Byline: Dominique Joly (a)(b)(g)(h)(i), Arnaud Mejean (a)(c)(h)(i), Jean-Michel Correas (a)(d)(h)(i), Marc-Olivier Timsit (a)(c)(h)(i), Virginie Verkarre (f)(h)(i), Sophie Deveaux (h)(i), Paul Landais (a)(b)(e), Jean-Pierre Grunfeld (a)(b), Stephane Richard (a)(b)(h)(i)(j)(k) Keywords: kidney; carcinoma; renal cell; von Hippel-Lindau disease; catheter ablation; France Abbreviations: GFR, glomerular filtration rate; NSS, nephron sparing surgery; RCC, renal cell carcinoma; RFA, radio frequency ablation; VHL, von Hippel Lindau Abstract: Patients with von Hippel-Lindau disease frequently have early, multiple and recurrent renal cell carcinoma. Renal cell carcinoma treatment, which must prevent metastatic disease and spare nephrons, has changed in the last 2 decades. We evaluated renal cell carcinoma treatments in the long term in a large series of patients with von Hippel-Lindau disease. Author Affiliation: (a) Faculte de Medicine, Universite Paris Descartes, Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (b) Service de Nephrologie, Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (c) Service d'Urologie, Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (d) Service de Radiologie, Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (e) Service de Biostatistique (EA 4067), Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (f) Service d'Anatomie Pathologique, Assistance Publique-HA[acute accent]pitaux de Paris, Paris, France (g) Institut National de la Sante et de la Recherche Medicale U845, HA[acute accent]pital Necker-Enfants Malades, Paris, France (h) Centre de Reference Cancers Rares Institut National du Cancer, Predispositions hereditaires au cancer du rein de l'adulte, Assistance Publique-HA[acute accent]pitaux de Paris, Le Kremlin-BicA*tre, France (i) Service d'Urologie, HA[acute accent]pital de BicA*tre, Le Kremlin-BicA*tre, France (j) Genetique Oncologique Ecole Pratique des Hautes Etudes, Institut National de la Sante et de la Recherche Medicale U753, Institut de cancerologie Gustave Roussy Villejuif, Le Kremlin-BicA*tre, France (k) Faculte de Medecine Paris-Sud, Le Kremlin-BicA*tre, France Article History: Received 12 October 2010 Article Note: (footnote) Supported by grants from the French National Cancer Institute, Rein and Reseau National Predispositions hereditaires au cancer du rein and French Ligue Nationale contre le Cancer, Comites du Cher, de l'Indre et de l'Allier., For another article on a related topic see page 2353 .
pubElsevier B.V.
lad01gale_ofa
pages2056-2060
doi10.1016/j.juro.2011.02.007
eissn15273792
date2011-06-01